Mirae Asset Global Investments’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69.5M | Sell |
|
|||||
|
2025
Q1 | $85.4M | Buy |
|
|||||
|
2024
Q4 | $63.2M | Buy |
|
|||||
|
2024
Q3 | $57.4M | Buy |
|
|||||
|
2024
Q2 | $40M | Buy |
|
|||||
|
2024
Q1 | $31.4M | Buy |
|
|||||
|
2023
Q4 | $19.5M | Sell |
|
|||||
|
2023
Q3 | $17.3M | Buy |
|
|||||
|
2023
Q2 | $14.1M | Buy |
|
|||||
|
2023
Q1 | $10.3M | Sell |
|
|||||
|
2022
Q4 | $25.3M | Buy |
|
|||||
|
2022
Q3 | $9.1M | Sell |
|
|||||
|
2022
Q2 | $10.1M | Buy |
|
|||||
|
2022
Q1 | $7.06M | Sell |
|
|||||
|
2021
Q4 | $7.22M | Sell |
|
|||||
|
2021
Q3 | $6.43M | Buy |
|
|||||
|
2021
Q2 | $5.37M | Sell |
|
|||||
|
2021
Q1 | $4.4M | Sell |
|
|||||
|
2020
Q4 | $41.4M | Buy |
|
|||||
|
2020
Q3 | $22.8M | Buy |
|
|||||
|
2020
Q2 | $20.1M | Buy |
|
|||||
|
2020
Q1 | $6.7M | Sell |
|
|||||
|
2019
Q4 | $7.59M | Buy |
|
|||||
|
2019
Q3 | $3.43M | Hold |
|
|||||
|
2019
Q2 | $3.38M | Hold |
|
|||||
|
2019
Q1 | $3.47M | Buy |
|
|||||
|
2018
Q4 | $2.56M | Sell |
|
|||||
|
2018
Q3 | $4.49M | Buy |
|
|||||
|
2018
Q2 | $3.22M | Sell |
|
|||||
|
2018
Q1 | $5.56M | Buy |
|
|||||
|
2017
Q4 | $5.64M | Buy |
|
|||||
|
2017
Q3 | $3.48M | Buy |
|
|||||
|
2017
Q2 | $2.83M | Buy |
|
|||||
|
2017
Q1 | $416K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $3.83M | Buy |
|
|||||
|
2015
Q3 | $3.15M | Sell |
|
|||||
|
2015
Q2 | $3.47M | Buy |
|
|||||
|
2015
Q1 | $3.32M | Buy |
|
|||||
|
2014
Q4 | $2.62M | Buy |
|
|||||
|
2014
Q3 | $1.83M | Sell |
|
|||||
|
2014
Q2 | $2.12M | Buy |
|
|||||
|
2014
Q1 | $1.6M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $508K | Sell |
|
|||||
|
2013
Q2 | $573K | Buy |
|